antidepressant – P.S. You Should Know…

First head-to-head trial pits psychedelic therapy against antidepressant

May 2, 2021

“The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression measure revealing no significant difference between the two treatments, but a number of secondary measures notably favoring psilocybin.” | learn more

under the microscope

FDA approves new antidepressant containing ketamine

April 21, 2019

“Esketamine represents the first depression drug in years to be approved that works via a completely different mechanism in the brain, as compared to the previous generation of medications. For many with treatment-resistant depression, the new drug offers newfound hope […]